Rare diseases
Investigational molecules
Locations
2 Boulevard Tonnelle, 37000 Tours, France
The sponsor supports research in acute myeloid leukemia across both treatment-naive and relapsed settings, with interest in molecularly defined disease such as FLT3-mutated AML and IDH1-mutated AML. Its portfolio also includes work in blastic plasmacytoid dendritic cell neoplasms, reflecting a focus on aggressive hematologic malignancies.
These studies place emphasis on disease control in older adults and on biologically targeted approaches within myeloid cancer care.
French Innovative Leukemia Organization (F.I.L.O.). runs clinical trials in conditions such as Acute myeloid leukaemia, Chronic lymphocytic leukaemia, Blastic plasmacytoid dendritic cell neoplasia, Richter's syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceFranceFranceFranceFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
